Cornerstone Financial Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Cornerstone Financial Management's BMY Position: Q2 2026 in Review
Cornerstone Financial Management increased its Bristol-Myers Squibb (BMY) stake by 68% in Q2 2026, buying an estimated $6.83K and bringing the position to 294 shares worth $16.9K. The position accounts for 0.01% of the portfolio, ranked #313.
Cornerstone Financial Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cornerstone Financial Management held 294 shares of Bristol-Myers Squibb worth $16.9K as of Q2 2026.
- Cornerstone Financial Management bought 119 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.83K.
- Bristol-Myers Squibb made up 0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #313 holding.
- Cornerstone Financial Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.